Patient Portal

Michael J. Naughton, MD

Assistant Professor, Medicine
Division of Oncology
Section of Medical Oncology

Specialty Areas

Breast Oncology
Medical Oncology
Breast Health
Oncology

Board Certifications

Internal Medicine
Oncology

Hospital Affiliations

Barnes-Jewish Hospital
Barnes-Jewish West County Hospital

Areas of Clinical Interest

Cancer, breast cancer, oncology

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Barnes-Jewish West County Hospital
Medical Building Two

10 Barnes West Drive
Creve Coeur, MO 63141

Suite: 100
Office Phone: 314-996-8270
Fax: 314-996-8277

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110

Floor: 7
Office Phone: (314) 362-5196

Education

Education

Chief Resident: Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 2000
Fellowship: Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri 1999
Residency: Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 1996
Medical Degree: State University of New York at Buffalo, Buffalo, New York 1993
B.A.: Williams College, Williamstown, Massachusetts 1989

Publication & Research

Publication & Research

Parental longevity predicts healthy ageing among women.
Shadyab AH, Manson JE, Li W, Gass M, Brunner RL, Naughton MJ, Cannell B, Howard BV, LaCroix AZ
Age Ageing. 2018 Aug 15; doi: 10.1093/ageing/afy125.

PMID:
    30124748
    [PubMed - as supplied by publisher]
Related citations


Bone Health and Survival in Women With Multiple Myeloma.
Rosko AE, Hade EM, Li W, Ing S, Jackson RD, Paskett ED, Naughton MJ
Clin Lymphoma Myeloma Leuk. 2018 Sep; 18(9)597-602.e1. doi: 10.1016/j.clml.2018.06.002.

PMID:
    30049515
    [PubMed - in process]
Related citations


Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant.
Rosko AE, Huang Y, Benson DM, Efebera YA, Hofmeister C, Jaglowski S, Devine S, Bhatt G, Wildes TM, Dyko A, Jones D, Naughton MJ, Byrd JC, Burd CE
J Geriatr Oncol. 2018 Jul 5; pii: S1879-4068(18)30157-7. doi: 10.1016/j.jgo.2018.05.015.

PMID:
    29983352
    [PubMed - as supplied by publisher]
Related citations


Change in longitudinal trends in sleep quality and duration following breast cancer diagnosis: results from the Women's Health Initiative.
Beverly CM, Naughton MJ, Pennell ML, Foraker RE, Young G, Hale L, Feliciano EMC, Pan K, Crane TE, Danhauer SC, Paskett ED
NPJ Breast Cancer. 2018; 415. doi: 10.1038/s41523-018-0065-7.

PMID:
    29978034
    [PubMed]
Related citations


Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer CE Jr, Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Goldhirsch A, Regan MM, SOFT and TEXT Investigators and the International Breast Cancer Study Group.
N Engl J Med. 2018 Jul 12; 379(2)122-137. doi: 10.1056/NEJMoa1803164.

PMID:
    29863451
    [PubMed - indexed for MEDLINE]
Related citations


Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105.
Naughton MJ, Case LD, Peiffer A, Chan M, Stieber V, Moore D, Falchuk S, Piephoff J, Edenfield W, Giguere J, Loghin M, Shaw EG, Rapp SR
Neurooncol Pract. 2018 May; 5(2)114-121. doi: 10.1093/nop/npx016.

PMID:
    29770225
    [PubMed]
Related citations


Self-reported adherence and biomarker levels of CoQ10 and alpha-tocopherol.
Vitolins MZ, Case LD, Rapp SR, Lively MO, Shaw EG, Naughton MJ, Giguere J, Lesser GJ
Patient Prefer Adherence. 2018; 12637-646. doi: 10.2147/PPA.S158682.

PMID:
    29731611
    [PubMed]
Related citations


Fear of recurrence among older breast, ovarian, endometrial, and colorectal cancer survivors: Findings from the WHI LILAC study.
Krok-Schoen JL, Naughton MJ, Bernardo BM, Young GS, Paskett ED
Psychooncology. 2018 Jul; 27(7)1810-1815. doi: 10.1002/pon.4731.

PMID:
    29644766
    [PubMed - in process]
Related citations


Emerging Perspectives on mTOR Inhibitor-Associated Pneumonitis in Breast Cancer.
Alvarez RH, Bechara RI, Naughton MJ, Adachi JA, Reuben JM
Oncologist. 2018 Jun; 23(6)660-669. doi: 10.1634/theoncologist.2017-0343.

PMID:
    29487226
    [PubMed - in process]
Related citations


Evaluation of [<sup>89</sup>Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.
Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA
Breast Cancer Res Treat. 2018 Jun; 169(3)523-530. doi: 10.1007/s10549-018-4696-z.

PMID:
    29442264
    [PubMed - in process]
Related citations


Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.
Gabani P, Cyr AE, Zoberi JE, Ochoa LL, Matesa MA, Thomas MA, Garcia J, Margenthaler JA, Naughton MJ, Ma C, Sanati S, Zoberi I
Brachytherapy. 2018 Jan - Feb; 17(1)171-180. doi: 10.1016/j.brachy.2017.09.009.

PMID:
    29089275
    [PubMed - indexed for MEDLINE]
Related citations


Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women's Health Initiative.
Felix AS, Lehman A, Foraker RE, Naughton MJ, Bower JK, Kuller L, Sarto GE, Stefanick ML, Van Horn L, Jackson RD, Paskett ED
Cancer Epidemiol. 2017 Dec; 5162-67. doi: 10.1016/j.canep.2017.10.009.

PMID:
    29049937
    [PubMed - indexed for MEDLINE]
Related citations


Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ, Loprinzi CL, Chaudhari AMW, Lustberg MB
Breast Cancer Res Treat. 2017 Jul; 164(1)69-77. doi: 10.1007/s10549-017-4230-8.

PMID:
    28374323
    [PubMed - indexed for MEDLINE]
Related citations


Association of sleep disturbance and sexual function in postmenopausal women.
Kling JM, Manson JE, Naughton MJ, Temkit M, Sullivan SD, Gower EW, Hale L, Weitlauf JC, Nowakowski S, Crandall CJ
Menopause. 2017 Jun; 24(6)604-612. doi: 10.1097/GME.0000000000000824.

PMID:
    28141665
    [PubMed - indexed for MEDLINE]
Related citations


Health Care, Business, and Ethics: The Goods We Hold in Common.
Naughton MJ
Health Prog. 2016 Nov-Dec; 97(6)21-5.

PMID:
    30040346
    [PubMed - indexed for MEDLINE]
Related citations


Wireless communication system via nanoscale plasmonic antennas.
Merlo JM, Nesbitt NT, Calm YM, Rose AH, D'Imperio L, Yang C, Naughton JR, Burns MJ, Kempa K, Naughton MJ
Sci Rep. 2016 Aug 24; 631710. doi: 10.1038/srep31710.

PMID:
    27555451
    [PubMed]
Related citations


Shielded Coaxial Optrode Arrays for Neurophysiology.
Naughton JR, Connolly T, Varela JA, Lundberg J, Burns MJ, Chiles TC, Christianson JP, Naughton MJ
Front Neurosci. 2016; 10252. doi: 10.3389/fnins.2016.00252.

PMID:
    27375415
    [PubMed]
Related citations


Global Quality of Life Among WHI Women Aged 80 Years and Older.
Naughton MJ, Brunner RL, Hogan PE, Danhauer SC, Brenes GA, Bowen DJ, Snively BM, Goveas JS, Saquib N, Zaslavsky O, Shumaker SA
J Gerontol A Biol Sci Med Sci. 2016 Mar; 71 Suppl 1S72-8. doi: 10.1093/gerona/glv056.

PMID:
    26858327
    [PubMed - indexed for MEDLINE]
Related citations


Longitudinal Cognitive Trajectories of Women Veterans from the Women's Health Initiative Memory Study.
Padula CB, Weitlauf JC, Rosen AC, Reiber G, Cochrane BB, Naughton MJ, Li W, Rissling M, Yaffe K, Hunt JR, Stefanick ML, Goldstein MK, Espeland MA
Gerontologist. 2016 Feb; 56(1)115-25. doi: 10.1093/geront/gnv663.

PMID:
    26615021
    [PubMed - indexed for MEDLINE]
Related citations


Aluminum Nanowire Arrays via Directed Assembly.
Nesbitt NT, Merlo JM, Rose AH, Calm YM, Kempa K, Burns MJ, Naughton MJ
Nano Lett. 2015 Nov 11; 15(11)7294-9. doi: 10.1021/acs.nanolett.5b02408.

PMID:
    26505906
    [PubMed]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2017:

Company Name: Biotheranoustics

Royalties:

Equity: No

Consulting/Advisory Board: $1 - $9,999

Speaker Fees: $1 - $9,999

Reporting Date: May 01, 2018


Company Name: Novartis

Royalties:

Equity: No

Consulting/Advisory Board: $1 - $9,999

Speaker Fees: $1 - $9,999

Reporting Date: May 01, 2018


Company Name: Genentech

Royalties:

Equity: No

Consulting/Advisory Board: $1 - $9,999

Speaker Fees: $20,000 - $39,999

Reporting Date: May 01, 2018


Company Name: Astrazenica

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $10,000 - $19,999

Reporting Date: May 01, 2018